<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-UGA-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Ouganda (l&apos;): Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Uganda: Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">African Field Epidemiology Network</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
  </participating-org>
  <participating-org ref="US-EIN-27-1414646" role="4" type="21">
   <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="US-EIN-91-1157127" role="4">
   <narrative xml:lang="EN">PATH</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Uganda</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="UG" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="UG" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Kampala</narrative>
   </name>
   <administrative code="UG" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>0.31628 32.58219</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1748581</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">3126511</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">2304285</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">7521</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="UGAPEF-TCA-CDC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">80000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-CHAI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">19128</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-PATH2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">60640</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">7842</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">1045735</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">535235</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-AFENET2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">144214</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-AFENET (African Field Epidemiology Network)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">African Field Epidemiology Network</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-CDC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">30000</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-CHAI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">110461</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-PATH2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">495341</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">21644</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1572669</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">752182</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-AFENET2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">141370</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-AFENET (African Field Epidemiology Network)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">African Field Epidemiology Network</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-CDC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">10000</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-CHAI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">52576</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-PATH2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">436732</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">12000</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">1050059</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">601549</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="UGAPEF-TCA-CHAI2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">7521</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000000">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-14"></transaction-date>
   <value currency="USD" value-date="2021-01-14">144214</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AFENET (African Field Epidemiology Network)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">African Field Epidemiology Network</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001924">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-09"></transaction-date>
   <value currency="USD" value-date="2021-06-09">109639</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AFENET (African Field Epidemiology Network)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">African Field Epidemiology Network</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100007219">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">15865</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AFENET (African Field Epidemiology Network)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">African Field Epidemiology Network</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000914">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">60000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000748">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-03"></transaction-date>
   <value currency="USD" value-date="2019-12-03">20000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001736">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">30000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001205">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-23"></transaction-date>
   <value currency="USD" value-date="2021-03-23">10000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001026">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">-80708</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001193">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">104529</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001325">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-76461</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006983">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">42497</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000979">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-17"></transaction-date>
   <value currency="USD" value-date="2019-12-17">11471</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000219">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">17800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000921">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-21"></transaction-date>
   <value currency="USD" value-date="2020-04-21">36590</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002095">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-09"></transaction-date>
   <value currency="USD" value-date="2020-06-09">43420</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002094">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-09"></transaction-date>
   <value currency="USD" value-date="2020-06-09">9575</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-17800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">17800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001511">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-13"></transaction-date>
   <value currency="USD" value-date="2021-10-13">3237</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001280">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-13"></transaction-date>
   <value currency="USD" value-date="2021-10-13">3335</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002517">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-25"></transaction-date>
   <value currency="USD" value-date="2021-10-25">27598</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004988">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-15"></transaction-date>
   <value currency="USD" value-date="2021-11-15">10862</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">60640</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001178">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-14"></transaction-date>
   <value currency="USD" value-date="2020-05-14">25000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002734">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-06"></transaction-date>
   <value currency="USD" value-date="2020-07-06">36065</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003345">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-15"></transaction-date>
   <value currency="USD" value-date="2021-07-15">49388</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">-28006</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">28006</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">6938</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-468</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">733</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-30"></transaction-date>
   <value currency="USD" value-date="2020-09-30">14911</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000297">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-03"></transaction-date>
   <value currency="USD" value-date="2021-02-03">3625</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">1350</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">675</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000915">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">922707</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000229">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">123028</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000867">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">184541</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">922707</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-123028</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">123028</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">342393</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001377">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-30"></transaction-date>
   <value currency="USD" value-date="2021-03-30">307569</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003306">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-13"></transaction-date>
   <value currency="USD" value-date="2021-07-13">742490</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000916">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">501783</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000231">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">33452</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">502070</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-33452</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">33452</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">216660</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001826">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-27"></transaction-date>
   <value currency="USD" value-date="2021-04-27">167357</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003404">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-20"></transaction-date>
   <value currency="USD" value-date="2021-07-20">434192</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-uganda-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Uganda 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-uganda-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Uganda 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-uganda-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Uganda 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-uganda-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Uganda 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-uganda-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Uganda 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-uganda-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Uganda 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-uganda-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Uganda 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-uganda-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Uganda 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-07-27"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-UGA" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">SOP/guidelines for immunization waste disposal available and in use</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Work with UNEPI and NMS to develop SOPs/guidelines for Sustainable waste management of used immunisation waste and implementation of the plan. The activity implementaton will mainly cater for transport from districts to disposal sites.">
      <location ref="UG"></location>
     </target>
     <actual value="On Track">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">Development of the Medical Waste Disposal was overtaken by events. PATH supported a consultant who worked with partners to develop the guidelines which are ready and have been submitted to MOH for approval. UNICEF will use this budget line to print and distribute as soon as final approvals are made.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Work with UNEPI and NMS to develop SOPs/guidelines for Sustainable waste management of used immunisation waste and implementation of the plan. The activity implementaton will mainly cater for transport from districts to disposal sites.">
      <location ref="UG"></location>
     </target>
     <actual value="On Track">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">Development of the Medical Waste Disposal was overtaken by events. PATH supported a consultant who worked with partners to develop the guidelines which are ready and have been submitted to MOH for approval. UNICEF will use this budget line to print and distribute as soon as final approvals are made.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of districts to have capacity built for health workers and caregivers on importance of card retention, catch up vaccination &amp; vaccines being delivered in the 2YL</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish and strengthen the second year of life (2YL) immunization platform for introduction of vaccines in the second year of life (MR and booster doses)">
      <location ref="UG"></location>
     </target>
     <actual value="On Track">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">A focal point for 2YL platform at MOH has been identified; discussions have commenced to strategize implementation modalities;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">10 districts and over 200 health facilities with a functional eChild register submitting their Immunization facility data including vaccines management</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establishing of ehealth system- eChild register">
      <location ref="UG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">Discussions have commenced at country level to discuss modalities of implementation; however funds for this activity have not yet been disbursed to the country. These are part of TCA 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">70 districts and over 1,500 health facilities with a functional eChild register submitting their Immunization facility data including vaccines management.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establishing of ehealth system- eChild register">
      <location ref="UG"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">The allocated funds were grossly inadequate and hence were reprogrammed towards MOV. However resource mobilization is ongoing; lessons from the 10 districts planned to be implemented during TCA 2021 will inform next steps for other set of districts; COVID-19 vaccine roll out is another added advantage where DHIS2 and e register have been used that will also build a platform for routine immunization</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Activities/considerations to strengthen programmatic/financial sustainability integrated/reflected in FPP outputs</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop a financial sustainability plan for New Vaccine Introduction
- engage a national local consultant to undertake the activity
- Consultant engage different stakeholders including desk review to gather information
- Final plan developed and disseminated to stakeholders including parliamentarian committee responsible for health">
      <location ref="UG"></location>
     </target>
     <actual value="On Track">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">A local consultant has been identified working closely with an international consultant virtually to conduct an investment case for RI; The overall aim of an investment case assessment is to define the costs of inaction or the status quo response, to identify priority areas of action, and quantify the benefits of these actions.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Near Final investment case for routine immunization and new vaccine introduction disseminated to policy makers</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and present an investment case for vaccines for RI and new vaccine introductions (such as Men-A and 2nd dose MR, booster Td dose), I) Engage the School of Public health (Mak SPH) to conduct operational research to identify operational barriers including GDP and per capita income to delivery of immunization services II) Provide technical support to MoH to monitor the roadmap for implementation of Addis Declaration on immunization">
      <location ref="UG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">Consultant hired; data collection has commenced; progress concept note on methodology shared; anticipate to be completed by end quarter 3 of 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">An annual/rolling operational plan for immunisation developed by MOH/EPI (country-led, with capacity building component)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support dissemination and utilization of the District Immunization Expenditure Resource Tracking Tool (DIET) in all districts
-Engage a consultant who developed the tool in close collaboration with MOH /NEPI planning department to upload the tool on the DHIS2 platform
- Develop a national roll out plan of DIET
- Build capacity of national level users
- Build capacity of district users (CAO, CFO, DH financing officer, DHO, ADHO, Biost etc)
- Monitor utilization of the tool and ensure that data generated is used for JRF">
      <location ref="UG"></location>
     </target>
     <actual value="Major Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">Due to competing activities this has been reprogrammed to next year</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Roles and responsibilities for planning and budgeting for immunisation among all stakeholders involved mapped and agreed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support dissemination and utilization of the District Immunization Expenditure Resource Tracking Tool (DIET) in all districts
-Engage a consultant who developed the tool in close collaboration with MOH /NEPI planning department to upload the tool on the DHIS2 platform
- Develop a national roll out plan of DIET
- Build capacity of national level users
- Build capacity of district users (CAO, CFO, DH financing officer, DHO, ADHO, Biost etc)
- Monitor utilization of the tool and ensure that data generated is used for JRF">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">The resource tracking system was developed and shared with MOH next steps is to engage HMIS division to design ways of uploading it onto the DHIS2 platform and hence roll it out to the districts; resource mobilization has to be done to support the roll out of the system</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Identified activities/considerations to strengthen programmatic/financial sustainability integrated/reflected in the immunisation and health strategic and planning documents</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop a financial sustainability plan for New Vaccine Introduction
- engage a national local consultant to undertake the activity
- Consultant engage different stakeholders including desk review to gather information
- Final plan developed and disseminated to stakeholders including parliamentarian committee responsible for health">
      <location ref="UG"></location>
     </target>
     <actual value="On Track">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">The update is that a concept note was developed and shared with the IVD cluster. The next steps are to advertise the consultancy and engage the best selected candidate. This has been initiated</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Proportion of private health facilities in Jinja, Kampala, Wakiso and Iganga conducting immunization services and timely reporting through appropriate channels</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the capacity strengthening, regulation, monitoring and supervision of the private health care facilities providing immunization services in the Urban settings (Wakiso, Iganga, Kampala and Jinja). 1) Carry out capacity building and review of the private health care facilities including the data management and compliance with Uganda&apos;s immunization guideline; 2) quarterly follow up, oversight and review">
      <location ref="UG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">During 2021, focus has been on ensuring continuity of essential health services in the urban setting, support was provided in (i) Vaccine distribution in the districts of KCCA and Wakiso to improve access to immunisation services (ii) Support to immunisation microplanning and coordination (iii) support to functionalize static and outreach services. Due to COVID-19 pandemic there has been a delay in engaging Uganda Pediatric Association to conduct private health facility capacity building and review. This is planned in third quarter of 2021. UNICEF Uganda has initiated a process to engage Uganda Pediatric Association (UPA) to support at national and district level with a special focus on urban districts to address immunisation inequities The expected outputs include strengthened capacity of Regional Referral Hospital Community Health Departments to plan and implement ACSM interventions to promote routine immunisation; institute regional champions and decision makers to advocate for and promote Routine immunisation; and sensitizing and supporting members of Uganda Medical Association, Uganda Pediatric Association, Uganda Nurses, Midwife and Public Health cadres and associations to actively get involved in media and community mobilisation efforts for routine immunisation (linked to supporting Urban Immunisation). 
Progress made to date to engage UPA include the development and discussion of the TOR and the activities to be implemented with the related budgets. All required documentation is almost complete waiting for the easing of the lockdown before funds are released.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">[BLANK]</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the capacity strengthening, regulation, monitoring and supervision of the private health care facilities providing immunization services in the Urban settings (Wakiso, Iganga, Kampala and Jinja).

1) Carry out capacity building and review of the private health care facilities including the data management and compliance with Uganda&apos;s immunization guideline; 
2) quarterly follow up, oversight and review">
      <location ref="UG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">During 2021, focus has been on ensuring continuity of essential health services in the urban setting, support was provided in (i) Vaccine distribution in the districts of KCCA and Wakiso to improve access to immunisation services (ii) Support to immunisation microplanning and coordination (iii) support to functionalize static and outreach services. Due to COVID-19 pandemic there has been a delay in engaging Uganda Pediatric Association to conduct private health facility capacity building and review. This is planned in third quarter of 2021. UNICEF Uganda has initiated a process to engage Uganda Pediatric Association (UPA) to support at national and district level with a special focus on urban districts to address immunisation inequities The expected outputs include strengthened capacity of Regional Referral Hospital Community Health Departments to plan and implement ACSM interventions to promote routine immunisation; institute regional champions and decision makers to advocate for and promote Routine immunisation; and sensitizing and supporting members of Uganda Medical Association, Uganda Pediatric Association, Uganda Nurses, Midwife and Public Health cadres and associations to actively get involved in media and community mobilisation efforts for routine immunisation (linked to supporting Urban Immunisation).</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the capacity strengthening, regulation, monitoring and supervision of the private health care facilities providing immunization services in the Urban settings (Wakiso, Iganga, Kampala and Jinja).

1) Carry out capacity building and review of the private health care facilities including the data management and compliance with Uganda&apos;s immunization guideline; 
2) quarterly follow up, oversight and review">
      <location ref="UG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">During 2021, focus has been on ensuring continuity of essential health services in the urban setting, support was provided in (i) Vaccine distribution in the districts of KCCA and Wakiso to improve access to immunisation services (ii) Support to immunisation microplanning and coordination (iii) support to functionalize static and outreach services. Due to COVID-19 pandemic there has been a delay in engaging Uganda Pediatric Association to conduct private health facility capacity building and review. This is planned in third quarter of 2021. UNICEF Uganda has initiated a process to engage Uganda Pediatric Association (UPA) to support at national and district level with a special focus on urban districts to address immunisation inequities The expected outputs include strengthened capacity of Regional Referral Hospital Community Health Departments to plan and implement ACSM interventions to promote routine immunisation; institute regional champions and decision makers to advocate for and promote Routine immunisation; and sensitizing and supporting members of Uganda Medical Association, Uganda Pediatric Association, Uganda Nurses, Midwife and Public Health cadres and associations to actively get involved in media and community mobilisation efforts for routine immunisation (linked to supporting Urban Immunisation).</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the capacity strengthening, regulation, monitoring and supervision of the private health care facilities providing immunization services in the Urban settings (Wakiso, Iganga, Kampala and Jinja). 1) Carry out capacity building and review of the private health care facilities including the data management and compliance with Uganda&apos;s immunization guideline; 2) quarterly follow up, oversight and review">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">The Urban Immunisation Communication Plan has been developed and finalized. A literature/desk review was conducted by the consultant followed by a Rapid Assessment on factors affecting demand for immunisation services in urban settings conducted in March 2021. The assessment was conducted in high densely populated urban settings of 7 districts of Kampala, Wakiso, Mukono, Jinja, Iganga, Gulu and Mbarara. A total of 17 urban settings in informal settlements and high-end social class communities in 7 districts were selected and covered during the rapid assessment. The consultant also caried out key informant interviews with key stakeholders including the Ministry of Health, Implementing partners, District, City and Municipal leaders. The key findings were used to inform the development of a draft Urban Immunisation Communication Plan. A review meeting was held on 14 July 2021 to review the Urban Immunisation Communication Plan followed by a consensus and validation meeting held on 29 July 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Regional teams trained and available for supporting the EPI program to improve immunization services in the districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical and financial support to 14 Regional referral hospital community health departements to conduct mentorship and supervision of the districts in the region. i) Identifying the regional teams 2)Building capacity in the regional teams to conduct supervision and on-job mentoring using ODK tool. 3) Technical support to poorly perfoming districts in the 14 regions">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">In Uganda, provision of immunisation services is the mandate of local governments. Among the oversight and stewardship roles of MOH/UNEPI, support supervision and on job mentoring is key to ensure quality in health services delivery including immunization. However, due to the increasing numbers of districts, supervision of immunisation service delivery was identified as inadequate during the November 2019 Gavi JA. Each of the 14 Regional Referral Hospitals (RRH), has a Community Health Department (CHD) that by structure is expected to support selected number of districts. However, the RRH CHD have minimal resources including staffing and skill to effectively provide the support supervision role. The 2019 Gavi JA prioritized Gavi funding through PEF/ CA 2020 strengthening the capacity of the RRH CHDs to provide technical backstopping for Communicable &amp; Vaccine Preventable Disease Control in districts. 
WHO, UNICEF, AFENET/CDC and USAID/MCHN worked together to ensure the proposed activities are synergistically implemented. A concept note, implementation plan and resource materials were developed, and consensus built under UNEPI leadership. UNICEF supported the national level training of 30 trainers and 8 RRH. In each of the 8 RRH, 30 officers referred to as Regional Immunisation Supervision and Mentorship team (RISMT) were trained and will be responsible for supporting 76 districts. The strategy of building RISMTs presents opportunity to leverage the already existing regional resource and government structures to strengthen and own Immunization. Financial support is required for the RISMT to conduct regular regional supportive supervision and monitoring in the catchment districts at least twice annually. The regional teams are being used by MoH to support other health service delivery. The teams have supported the Corvid 19 vaccine deployment.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Roadmap for improved integration of EPI with other PHC services</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support reduction of zero dose and under immunized children by 20% in 15 rural districts with high numbers of zero dose
- Engage HSIP to develop an e registry for routine immunization
- Engage a CSO to undertake the district support
- Identify districts through data analysis including triangulation for districts with &gt;2000 zero dose children for past 3 years
- Map the areas with high numbers 
- Develop an evidence based strategic plan to reach the children through consultative workshops at district level
- Support districts to deliver comphrehensive RMNCAH services using PHC funds
- Conduct a monitoring and evaluation framework to document lessons and best practices">
      <location ref="UG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">Funds to initiate this activity have not yet been received in the country. However some discussions have started to develop a concept note.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support reduction of zero dose and under immunized children by 20% in 15 rural districts with high numbers of zero dose - Engage HSIP to develop an e registry for routine immunization - Engage a CSO to undertake the district support - Identify districts through data analysis including triangulation for districts with &gt;2000 zero dose children for past 3 years - Map the areas with high numbers - Develop an evidence based strategic plan to reach the children through consultative workshops at district level - Support districts to deliver comphrehensive RMNCAH services using PHC funds - Conduct a monitoring and evaluation framework to document lessons and best practices">
      <location ref="UG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">The Ministry of Health suggested that WHO works together with the Smart Paper Technology (SPT) to undertake an e-registry of the immunization data and map areas with high numbers of zero dose. Due to competing activities by SPT which is currently rolling out into 10 districts, this has been delayed but will be focus in the first quarter of 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery approach suitable to reach missed communities identified and endorsed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support reduction of zero dose and under immunized children by 20% in 15 rural districts with high numbers of zero dose
- Engage HSIP to develop an e registry for routine immunization
- Engage a CSO to undertake the district support
- Identify districts through data analysis including triangulation for districts with &gt;2000 zero dose children for past 3 years
- Map the areas with high numbers 
- Develop an evidence based strategic plan to reach the children through consultative workshops at district level
- Support districts to deliver comphrehensive RMNCAH services using PHC funds
- Conduct a monitoring and evaluation framework to document lessons and best practices">
      <location ref="UG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">Initiated discussions with SPT since they are engaged with working with UNEPI in electronic capture of immunization Data. This has been delayed due to competing activities especially in regards to COVID-19</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Communication and social mobilization strategy developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Engagement of health and non-health government extension workers/ structures (e.g. parish and sub county chiefs, teachers, CDOs etc.) to support EPI Comms and strengthen routine immunisation. 
i) Orientation, action planning and review meetings with DHO, DHE and district leadership to appreciate the need to prioritise EPI Comms. with a focus on RI, HPV and Td (zoom meeting, no funds for physical meeting done virtually led by the consultant)">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">A C4D EPI consultant was hired to support the Ministry of Health, Health Promotion Department and UNEPI division. The consultant?s key deliverables included the engagement of health and non-health stakeholders to promote EPI services and increase demand/uptake for routine immunisation. A stakeholder engagement plan was developed to engage both health and non-health stakeholders. In Busoga region, 8 districts were engaged, and technical support provided on EPI Communication and development of action plans and review meetings. A total of 148 health stakeholders (DHT members, Health Facility staff, Health workers and VHTs) and 200 non-health stakeholders (CDOs, LC1s, Parents/Caregivers) were engaged. In central region, 7 districts were engaged, and technical support provided on EPI Communication and development of action plans. A total of 155 health stakeholders (DHT members, Health Facility staff, Health workers and VHTs) and 32 non-health stakeholders (CDOs, LC1s, Community Leaders, Parents/Caregivers) were engaged. The consultant also provided technical support to 9 of the 14 Regional Referral Community Health Departments in Advocacy, Communication and Social Mobilisation (ACSM). These included: Masaka, Jinja, Arua, Soroti, Naguru, Gulu, Lira, Mbale and Kabale where participants were oriented on the key EPI ACSM issues including demand generation issues during service delivery which demotivate parents and caregivers, the lack of IPC skills and the attitude of health workers when providing services.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Multi-media campaign on Routine and HPV Immunsiation, ICHDs implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen the advocacy, communication and social mobilization to maximise &apos;reach&apos; of zero dose and under immunised target population in urban settings and rural communities through:
i) Improving mobilisation, awareness and demand for immunisation through airing of multimedia campaigns (in 2 quarters) for Routine and HPV immunisation including April and October ICHDs. ii) Dissemination of the Urban Immunisation Communication Plan to improve demand and uptake for routine imunisation services in urban settings (zoom meeting, no funds for physical meeting done virtually led by the consultant)">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">Mobilisation and awareness at community level for routine immunisation was mainly supported during the October ICHDs through radio, U-Report and social media. Through U-Report 531,436 U-Reporters were engaged. A total of 36,750 U-Reporters nationally consented to receiving ICHDs informational messages throughout the month of October. A series of 08 Informational messages, 04 feedback questions were sent out to U-Reporters to get the general feel about the exercise. 98% of the U-Reporters who responded to the initial message were interested in receiving more information about ICHDs. 65% of U-Reporters reported to be aware/heard of the ICHDs. When asked how they heard about ICHD, the majority, 35%, indicated Radio followed by through U-Report (39%), VHT or Health worker (17%) and 6% through social media. Overall, 58% of U-Reporters received or knew someone who received ICHD services during the month of October. When asked about services that were being offered, the majority indicated immunisation, vaccination followed by deworming and Polio. Through UNICEF social media platforms (Instagram and Twitter) we were able to reach 111,215 people. Radio spots for ICHDs were aired on 27 radio stations.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Progress report on implementation of the Urban Health Communication Strategy and registration of VHTs and children</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen the  advocacy, communication and social&#xA0;mobilization to maximise &apos;reach&apos; of target population in urban settings through:
1) Development and finalisation of Urban Health communication guideline and implementation plan
2) Implement the urban immunisation communication plan through: Targeted information dissemination, dialogues/meetings with urban elites, informal settlements, refugees, schools, working caretakers
3) Scale up demand generation through registration of VHTs, Registration of children in municipalities, mobilisation &amp; awareness at community level, address vaccine hesitancy and immunisation refusals">
      <location ref="UG"></location>
     </target>
     <actual value="On Track">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">The Urban Immunisation Communication Plan was made to maximize &apos;reach&apos; of target population in urban settings. The plan provides a framework for action and connects and mobilizes partners and stakeholders in immunisation around a common cause. The plan aims to bring change among individuals, communities, social networks, and policy makers who will be connected through participatory activities and dialogue to participate in demand generation activities. To gather evidence to inform development of this plan, a rapid assessment was conducted in 7 districts of Kampala, Wakiso, Mukono, Jinja, Iganga, Gulu and Mbarara. targeting 17 urban settings in densely populated informal settlements and high-end social class communities. The draft plan is undergoing finalization reviews before dissemination, planned for August 2021. 
Despite the challenges associated with the Corvid 19 pandemic, the 12 districts that implemented the registration of VHTs and children were followed up to review district continuity plans, assess progress in implementation and propose strategies for increasing child registration to improve RI services. 
Community mobilisation was enhanced during the April CHDs and AVW through radio, U-Report and social media. U-Report engaged 512,629 U-Reporters. Overall,136,974 responses and comments were received. 70% of U-Reporters received or knew someone who received CHD services.. 
To address vaccine hesitancy and immunisation refusals, opportunities to engage with the district health educators (DHE) included: - virtual training in preparation for the Corvid 19 vaccine introduction. The second engagement was during the training of Regional Referral Hospitals supervision teams that included all the DHEs. Mapping of religious groups/cults and resistant communities to address vaccine hesitancy and immunisation refusals done in Jinja, Mukono, Iganga and Kampala and Arua. Moving forward, DHEs have developed action plans to address identified obstacles.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen the  advocacy, communication and social&#xA0;mobilization to maximise &apos;reach&apos; of target population in urban settings through:
1) Development and finalisation of Urban Health communication guideline and implementation plan
2) Implement the urban immunisation communication plan through: Targeted information dissemination, dialogues/meetings with urban elites, informal settlements, refugees, schools, working caretakers
3) Scale up demand generation through registration of VHTs, Registration of children in municipalities, mobilisation &amp; awareness at community level, address vaccine hesitancy and immunisation refusals">
      <location ref="UG"></location>
     </target>
     <actual value="On Track">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">The Urban Immunisation Communication Plan was made to maximize &apos;reach&apos; of target population in urban settings. The plan provides a framework for action and connects and mobilizes partners and stakeholders in immunisation around a common cause. The plan aims to bring change among individuals, communities, social networks, and policy makers who will be connected through participatory activities and dialogue to participate in demand generation activities. To gather evidence to inform development of this plan, a rapid assessment was conducted in 7 districts of Kampala, Wakiso, Mukono, Jinja, Iganga, Gulu and Mbarara. targeting 17 urban settings in densely populated informal settlements and high-end social class communities. The draft plan is undergoing finalization reviews before dissemination, planned for August 2021. 
Despite the challenges associated with the Corvid 19 pandemic, the 12 districts that implemented the registration of VHTs and children were followed up to review district continuity plans, assess progress in implementation and propose strategies for increasing child registration to improve RI services. 
Community mobilisation was enhanced during the April CHDs and AVW through radio, U-Report and social media. U-Report engaged 512,629 U-Reporters. Overall,136,974 responses and comments were received. 70% of U-Reporters received or knew someone who received CHD services.. 
To address vaccine hesitancy and immunisation refusals, opportunities to engage with the district health educators (DHE) included: - virtual training in preparation for the Corvid 19 vaccine introduction. The second engagement was during the training of Regional Referral Hospitals supervision teams that included all the DHEs. Mapping of religious groups/cults and resistant communities to address vaccine hesitancy and immunisation refusals done in Jinja, Mukono, Iganga and Kampala and Arua. Moving forward, DHEs have developed action plans to address identified obstacles.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Urban communication guidelines and implementation plan finalized and disseminated in 4 urban districts (Kampala, Wakiso, Jinja and Iganga</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen the advocacy, communication and social&#xA0;mobilization to maximise &apos;reach&apos; of target population in urban settings through: 1) Development and finalisation of Urban Health communication guideline and implementation plan 2) Implement the urban immunisation communication plan through: Targeted information dissemination, dialogues/meetings with urban elites, informal settlements, refugees, schools, working caretakers 3) Scale up demand generation through registration of VHTs, Registration of children in municipalities, mobilisation &amp; awareness at community level, address vaccine hesitancy and immunisation refusals">
      <location ref="UG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">The urban communication guidelines and plan has been developed and is currently being reviewed by MOH. Plans are underway to print the plan as soon as it is signed off and this will be followed with the implementation during August to October period. The consultant who developed the plan will continue with the implementation. The slow implementation has been due to Corvid 19 pandemic.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">14 regional champions advocating,creating awarness drives and mobilising for immunisation; social media plan developed and implemented; reports from the non-health stakeholder meetings in 22 districts; Monitoring reports,&#xA0;reach and coverage analysis of the Radio campaign</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Advocacy, Social Mobilisation and Communication through engagement of decision makers at national, district and community level to improve immunisation coverage: 1) Engagement and Linking of 14 regional champions and decision makers to support immunisation (Professional associations will be engaged -UPA, UMA, AUWD)? 2) Support the professional association develop and implement a Social media plan to support RI and HPV specifically, human interest stories (national and district level) (Professional associations will be engaged -UPA, UMA, AUWD)? 3)Provide technical support to the 14 regional Community health departments in advocacy, social mobilisation and communication 4) Improving mobilisation, awareness and demand for immunisation through Airing of comprehensive&#xA0; media messages and radio talk show appearances 2 quarters for routine and HPV immunisation covering including April and October ICHD.">
      <location ref="UG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF Uganda has initiated a process to engage Uganda Pediatric Association (UPA) to support at national and district level with a special focus on urban districts to address immunisation inequities The expected outputs include strengthened capacity of Regional Referral Hospital Community Health Departments to plan and implement ACSM interventions to promote routine immunisation; institute regional champions and decision makers to advocate for and promote Routine immunisation; and sensitizing and supporting members of Uganda Medical Association, Uganda Paediatric Association, Uganda Nurses, Midwife and Public Health cadres and associations to actively get involved in media and community mobilisation efforts for routine immunisation (linked to supporting Urban Immunisation)
The UPA engagement has delayed. The bottleneck has been identified and redress is underway. 
Improving mobilisation, awareness and demand for immunisation through airing of comprehensive media messages on radio, social media and through U-Report are ongoing. U-Report engaged 512,629 U-Reporters. Overall,136,974 responses and comments were received. 70% of U-Reporters received or knew someone who received CHD services. Through UNICEF social media platforms (Facebook, Instagram, and Twitter) we were able to reach 36,182 people. Media engagement during the April child health days and the events to mark the Africa vaccination week</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participation in continued school and facility level review meetings completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to MOH to monitor HPV Coverage Improvement Plan (CIP) implementation progress, identify challenges, propose solutions">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">Coverage improvement completed with MOH. Reports of work are attached to other milestones.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support provided to schools and health facilities to address gaps in planning and implementation</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct school and health facility supportive supervision in Kampala &amp; Wakiso">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">PATH engaged immunization teams to use onsite service points for example family planning clinics, OPD (out patient department) for vaccination in addition to community mobilization for the girls that missed first or second dose using VHTs (Village Health Teams). This was part of the MOHs immunization recovery plan. This has been an ongoing intervention in 2021 especially in Kampala, coverage for HPV has been persistently low.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support to and attendance at planning and TWG meetings is completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Nat?l TWG meetings and continued support for program refresh">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">PATH participated in the district and national TWG meetings.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participation in district MOE support completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assitance to district MOE (15 targeted districts) to support HPV vaccination">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">PATH engaged the Department of Education together with Department of health. However, this was not maximally done because schools were under lockdown. PATH met with DEOs and District Medical Team to prepare for massive immunization when children eventually come back to school.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assitance to district MOE (15 targeted districts) to support HPV vaccination">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">PATH engaged the Department of Education together with Department of health. However, this was not maximally done because schools were under lockdown. PATH met with DEOs and District Medical Team to prepare for massive immunization when children eventually come back to school.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participation in JA completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Participate in Gavi&apos;s annual Joint Appraisal and grant renewal processes to ensure continuity of HPV TA support">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">PATH participated in the MSD meeting held Feb 3-5, 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participation in district HPV review meetings completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Ongoing quarterly district review and learning meetings (15 targeted districts) to monitor program and coverage improvements">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">PATH supported the stakeholders meeting and provided supervision in April and May 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Ongoing quarterly district review and learning meetings (15 targeted districts) to monitor program and coverage improvements">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">PATH supported the stakeholders meeting and provided supervision in April and May 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Develop key messages, circulars, flyers with key messages targeting parents, school authorities, and leaders</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support for improved social mobilization for HPV uptake">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">Social mobilization through Radio and TV Talk- shows using pioneers of HPV to improve public trust and uptake of the vaccine by sharing evidence that taking HPV did not stop girls from producing children.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support to convene and facilitate performance review workshops for HPV and immunization at division level with key stakeholders</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Ongoing quarterly review meetings to monitor performance at division level (Kampala &amp; Wakiso)">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">Two engagements were done, in April and May. Private sector providers in Wakiso and Kampala were brought on board.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery related barriers of missed communities to access immunisation services identified and prioritized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical and financial support to selected poor perfoming(zero dose and underimmunised) and hard to reach districts through: 
i) Conduct supervision, mentorship and monitoring 
ii) Perfomance review meetings in selected poorly perfoming regions (zero dose and underimmunised) to discuss, identify, implement and monitor sustainable interventions to reach zero dose children and reduction of missed opportunities">
      <location ref="UG"></location>
     </target>
     <actual value="On Track">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">The 61 districts identified with large numbers &apos;Zero dose&apos; and &apos;Under immunised&apos; children, constitute 51% of the national target population with 241,755 zero dose and 184,150 under immunised children from 2018-2020 data. In 2021, RED/REC consultants support contributed to 6 percent reduction as compared to 2020 (55,857 zero dose and 39,201 under immunised). By September 2021, more than 40% of the 61 priority districts registered remarkable improvement in reducing the unreached children. The main areas of intervention were: 1) Technical support, capacity building, supervision, and mentorship for 2095 HWs covering 996 (48%) of the targeted health facilities; 2) Developing/updating FY 2021/2022 immunization micro plans to include identified inequities, actions to increase reach and required budget estimates; and 3) Performance review meetings focusing on monitoring of zero doze and under immunized children. Teams were empowered to smoothen out their work processes and innovation mainly in planning and data utilization at source. 
 To improve equity and access to immunisation through Effective Vaccine Management in all the 136 districts, UNICEF worked with MOH/UNEPI and NMS and held a meeting for the Assistant District Health Officers, District Cold Chain Technicians and Biostatisticians. The meetings created strong teamwork among the officers that should improve Vaccine Management data quality and reporting on the EVM KPIs. 398 district officers were oriented on EVM KPI, problems identified and solutions for improvement. The meeting recommended better/proper usage of EPI assets, recruitment to fill up vacant posts.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Tools and mechanisms to assess and monitor quality and acceptance of services developed and in use by countries</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support functionality of Uganda National Technical Advisory Immunization Group of experts and regional Immunization supervision teams">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">Sub working committees were established to review the questions at hand and 10 meetings were held. Two broad UNITAG meetings were also conducted; Capacity building efforts of selected members of UNITAG were also conducted; Due to COVID-19 pandemic several working groups have also been established to review service delivery within the context of the pandemic and also a COVID-19 vaccine working group. 
Regarding regional immunization teams ; trainings for the four regions were conducted; A total of 120 RISMT participants were trained; Participatory teaching and learning methods were used which included active participation
through brain storming, smaller group discussion, case studies, question and answer sessions,
demonstration and return demonstration</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Tools and approaches developed to improve and sustain quality and safety of immunisation services</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support functionality of Uganda National Technical Advisory Immunization Group of experts and regional Immunization supervision teams">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">The NITAG has been supported technically , since they are now receiving funding directly from GAVI. They however have submitted a protocol for research which WHO will be supported next year</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% (4813) of 4813 health facilities staff received skills and knowledge on AEFI reporting, management and investigation</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct in service training to roll out the vaccine Pharmacovigilance at the HF level including VAEMIS with close collaboration with NDA">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">The master TOT was expanded to 24 from seven who had earlier been trained; The TOT was immediately deployed to the selected districts to conduct a one day deep dive mentorship/training of the health workers including DHT; The number of health workers trained by level were 293 DHTs, 168 health workers from hospitals, 225 health workers from HCIVs, 871 health workers from HCIII, 977 health workers from HCII and 53 health workers from other health facilities were trained. In total 2,591 health workers were trained. from 44 districts. The biggest challenge was inadequate financial resources to cover more districts</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct in service training to roll out the vaccine Pharmacovigilance at the HF level including VAEMIS with close collaboration with NDA">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">The master TOT was expanded to 24 from seven who had earlier been trained; The TOT was immediately deployed to the selected districts to conduct a one day deep dive mentorship/training of the health workers including DHT; The number of health workers trained by level were 293 DHTs, 168 health workers from hospitals, 225 health workers from HCIVs, 871 health workers from HCIII, 977 health workers from HCII and 53 health workers from other health facilities were trained. In total 2,591 health workers were trained. from 44 districts. The biggest challenge was inadequate financial resources to cover more districts</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Twelve (12) of the planned monthly subcomittees on data/surveillance, Programme management and service delivery scheduled and conducted at the national level</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to the monthly EPI sub committees of Data/Surveillance, Program management and service delivery">
      <location ref="UG"></location>
     </target>
     <actual value="On Track">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">The routine planned monthly meetings conducted were four; however following the need to roll out COVID-19 vaccine these were adjusted to weekly and later during implementation to daily with the main focus on COVID-19 vaccine; review of surveillance and routine immunization data was integrated within the EPI technical meetings. Biggest challenge was competing priority to focus on rolling out COVID-19 vaccine data management tools with limited attention on having a deep dive on routine immunization data.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to the monthly EPI sub committees of Data/Surveillance, Program management and service delivery">
      <location ref="UG"></location>
     </target>
     <actual value="On Track">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">The routine planned monthly meetings conducted were four; however following the need to roll out COVID-19 vaccine these were adjusted to weekly and later during implementation to daily with the main focus on COVID-19 vaccine; review of surveillance and routine immunization data was integrated within the EPI technical meetings. Biggest challenge was competing priority to focus on rolling out COVID-19 vaccine data management tools with limited attention on having a deep dive on routine immunization data.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Tools and mechanisms to assess and monitor quality and acceptance of services developed and in use by countries</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide administrative support for top up allowance and provision of data bundles for teams at the surveilance sites to transmit data from the new vaccine sentinal sites to produce data that will monitor and evaluate new vaccine introduction ( Rota, PCV and Penta), and data analysis for timely use">
      <location ref="UG"></location>
     </target>
     <actual value="On Track">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">Monthly data from the four sentinel sites has been submitted on time; monthly site coordination meetings have been held; allowances for the teams have been paid; sites have been supplied with the laboratory supplies; awaiting for funds under TCA 2021 that the country has not yet received</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide administrative support for top up allowance and provision of data bundles for teams at the surveilance sites to transmit data from the new vaccine sentinal sites to produce data that will monitor and evaluate new vaccine introduction ( Rota, PCV and Penta), and data analysis for timely use">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">This activity has been undertaken and teams at the surveillance sites were supported with data bundles and top-up allowance</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Human Resources for Health</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Learning package for in-service training and performance management including supervision developed and tested</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support implementation of modified MLM in all districts and expansion of operational level training in 60 districts
- Support adaptation of MLM training modules for online and physical workshops of DHT and OPL
- Develop a roll out plan for MLM and OPL
- Facilitate in selected workshops
- conduct M and E of the MLM and OPL workshops">
      <location ref="UG"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">The funds allocated to this activity were inadequate and hence there were reprogrammed towards other areas under human resource component who supported MOH to develop concept note for MLM; the HSS grant under MOH has resources to support the MLM training</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Comprehensive in-service training and continuous professional education plans for vaccinators developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support implementation of modified MLM in all districts and expansion of operational level training in 60 districts
- Support adaptation of MLM training modules for online and physical workshops of DHT and OPL
- Develop a roll out plan for MLM and OPL
- Facilitate in selected workshops
- conduct M and E of the MLM and OPL workshops">
      <location ref="UG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">WHO has supported the Ministry of Health to revise and update the IIP manual. Also Regional Trainings of IIP has been undertaken. MLM training has been reprogrammed due to competing activities especially COVID-19</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Costing study completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to determine the cost effectiveness of different approaches to DTP booster dose introduction; school-based delivery, facility-based delivery, single cohort approach, and multiple cohort approach.">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">&quot;Reporting status: completed
Progress: An initial costing study was completed in May 2021. Findings were shared with Ministry of Health (MoH) in small internal meeting (due to COVID-19 restrictions). MoH requested additional costing analysis which is currently being planned. &quot;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Final report on study findings.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue technical assistance to determine the cost and cost effectiveness of different approaches to DTP booster dose introduction; school-based delivery, facility-based delivery, single cohort approach, and multiple cohort approach. Includes dissemination of the findings.">
      <location ref="UG"></location>
     </target>
     <actual value="Major Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">&quot;1. Major Delays 
2. DTP booster dose costing: phase 1 completed, phase 2 in progress with report to be available in early 2022. DTP booster dose modeling: development of model has commenced, Gavi represented on the expert reference group; results from first use in Uganda estimated to be available later in 2022. &quot;</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue technical assistance to determine the cost and cost effectiveness of different approaches to DTP booster dose introduction; school-based delivery, facility-based delivery, single cohort approach, and multiple cohort approach. Includes dissemination of the findings.">
      <location ref="UG"></location>
     </target>
     <actual value="Major Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">&quot;Reporting status: major delays
Progress: Health and economic effects of DTP booster dose introduction not yet completed. Modeling group has been identified though there have been delays with finalizing the contract due to the time taken for contract negociations with the institution. All parties are aware of the delay and actively working to finalize contract so the work can begin. Members for an expert reference group (incl. rep from Gavi) have been identified though formation of this group is awaiting pending contract approval. &quot;</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue technical assistance to determine the cost and cost effectiveness of different approaches to DTP booster dose introduction; school-based delivery, facility-based delivery, single cohort approach, and multiple cohort approach. Includes dissemination of the findings.">
      <location ref="UG"></location>
     </target>
     <actual value="Major Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">&quot;Reporting status: major delays
Progress: Health and economic effects of DTP booster dose introduction not yet completed. Modeling group has been identified though there have been delays with finalizing the contract due to the time taken for contract negociations with the institution. All parties are aware of the delay and actively working to finalize contract so the work can begin. Members for an expert reference group (incl. rep from Gavi) have been identified though formation of this group is awaiting pending contract approval. &quot;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Costing results to be presented at stakeholder consultation meeting that will inform country-level decisions about introduction of DTP booster doses.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue technical assistance to determine the cost and cost effectiveness of different approaches to DTP booster dose introduction; school-based delivery, facility-based delivery, single cohort approach, and multiple cohort approach. Includes dissemination of the findings.">
      <location ref="UG"></location>
     </target>
     <actual value="On Track">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">&quot;Reporting status: on track 
Progress: Initial delays due to COVID-19. Additional costing analysis is being planned (per milestone reporting from 2019) with estimated timeline for completed three months from start of contract period. Results will be presented to Ministry of Health and immunziation stakeholders in Uganda once finalized. &quot;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">10 national level CCE inventory managers trained on ODK-X app management</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3) Conduct 1day ODK-X managers training for 10 national CCE inventory managers">
      <location ref="UG"></location>
     </target>
     <actual value="Major Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">Due to lockdowns and COVID-19 response needs by stakeholders these activities are delayed anticipate completion of this activity in August/ September if COVID lockdowns are lifted</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3) Conduct 1day ODK-X managers training for 10 national CCE inventory managers">
      <location ref="UG"></location>
     </target>
     <actual>
      <location ref="UG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All (135) DCCT/As and EPI key stakeholders trained on the CCE app</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2) Conduct a 3days training for 135 district cold chain technicians/ assistants (DCCT/As) on ODK-X App usage">
      <location ref="UG"></location>
     </target>
     <actual value="Major Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">Due to lockdowns and COVID-19 response needs by stakeholders these activities are delayed but anticipate completion by December still</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2) Conduct a 3days training for 135 district cold chain technicians/ assistants (DCCT/As) on ODK-X App usage">
      <location ref="UG"></location>
     </target>
     <actual>
      <location ref="UG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">An updated CCE inventory using ODK-X completed in all regions/ districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4) Conduct a national CCE inventory update">
      <location ref="UG"></location>
     </target>
     <actual value="Major Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">Due to lockdowns and COVID-19 response needs by stakeholders these activities are delayed but anticipate completion by December still</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4) Conduct a national CCE inventory update">
      <location ref="UG"></location>
     </target>
     <actual>
      <location ref="UG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">An updated CCE inventory using ODK-X completed in all regions/districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5) Conduct regional and district support supervisions and onsite mentorship during CCE inventory updates">
      <location ref="UG"></location>
     </target>
     <actual value="Major Delays">
      <location ref="UG"></location>
      <comment>
       <narrative xml:lang="EN">Due to lockdowns and COVID-19 response needs by stakeholders these activities are delayed but anticipate completion by December still</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5) Conduct regional and district support supervisions and onsite mentorship during CCE inventory updates">
      <location ref="UG"></location>
     </target>
     <actual>
      <location ref="UG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A complete and robust ODK-X CCE inventory tool with all districts CCE data developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Finalize ODK-X CCE App development to include 135 districts CCE inventory data">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Continued use of ODK-X for CCE inventory update and maintenance tracking</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="6) Jointly monitor CCE performance and track maintenance activities">
      <location ref="UG"></location>
     </target>
     <actual>
      <location ref="UG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">End of project evaluation report shared with UNEPI and partners</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="7) Conduct end of project evaluation">
      <location ref="UG"></location>
     </target>
     <actual>
      <location ref="UG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Documentation and admin guide for app/ transfer of account rights to UNEPI</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="8) Handover of the management of the ODK-X CCE app management to UNEPI">
      <location ref="UG"></location>
     </target>
     <actual>
      <location ref="UG"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Covid-19 digital package installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="UG"></location>
     </target>
     <actual value="Completed">
      <location ref="UG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on COVID-19 digital data package and know how to use it.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="UG"></location>
     </target>
     <actual>
      <location ref="UG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3. EPI legacy data migrated 4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="UG"></location>
     </target>
     <actual>
      <location ref="UG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3. EPI legacy data migrated
4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="UG"></location>
     </target>
     <actual>
      <location ref="UG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Transition plan for EPI in place with agreed date for end of parallel system</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="UG"></location>
     </target>
     <actual>
      <location ref="UG"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
